EBAC
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
EBAC
Delisted
EBAC was delisted on the 2nd of March, 2023.
46 hedge funds and large institutions have $66.8M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
46
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.66M | |
| 2 | +$2.53M | |
| 3 | +$1.78M | |
| 4 |
SC
Sculptor Capital
New York
|
+$1.58M |
| 5 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$1.46M |
Top Sellers
| 1 | -$1.93M | |
| 2 | -$1.32M | |
| 3 | -$937K | |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$383K |
| 5 |
AMH
Apollo Management Holdings
New York
|
-$63.4K |